Quest Diagnostics Incorporated (LON:0KSX)

Market Cap	15.12B
Revenue (ttm)	7.89B
Net Income (ttm)	691.73M
Shares Out	n/a
EPS (ttm)	6.14
PE Ratio	21.86
Forward PE	n/a
Dividend	2.37 (1.38%)
Ex-Dividend Date	Apr 7, 2025

Volume	317
Average Volume	4,974
Open	169.00
Previous Close	172.21
Day's Range	169.00 - 171.82
52-Week Range	119.84 - 170.43
Beta	0.91
RSI	64.14
Earnings Date	Jan 31, 2025

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, govern...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1967
• Employees: 55,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KSX

Financial Performance

In 2024, Quest Diagnostics's revenue was $9.87 billion, an increase of 6.70% compared to the previous year's $9.25 billion. Earnings were $866.00 million, an increase of 1.88%.

Financial numbers in USD